Sign in

You're signed outSign in or to get full access.

R. Glenn Hubbard

Chairman of the Board at METLIFEMETLIFE
Board

About R. Glenn Hubbard

Independent Chairman of the Board of MetLife since May 1, 2019; age 66; MetLife director since 2007 (18 years of board service as of April 29, 2025) . Dean Emeritus and Russell L. Carson Professor of Economics and Finance at Columbia Business School; Ph.D. and A.M. from Harvard; B.A. and B.S. from University of Central Florida . Core credentials center on economic policy leadership (Chair, President’s Council of Economic Advisers; Chair, OECD Economic Policy Committee), regulated industry/government expertise, and investments oversight .

Past Roles

OrganizationRoleTenureCommittees/Impact
Columbia UniversityDean Emeritus, Graduate School of Business; Russell L. Carson Professor of Economics and Finance; Professor of Economics (Arts & Sciences)Dean Emeritus (2019–present); Professor roles since 1994/1997Academic leadership and finance/economics expertise supporting board risk, strategy and capital markets oversight
President’s Council of Economic AdvisersChairman2001–2003Led U.S. economic policy advisory; informs macro risk and policy oversight
OECDChairman, Economic Policy Committee2001–2003International policy coordination experience; global literacy
U.S. Department of the TreasuryDeputy Assistant Secretary for Tax Policy1991–1993Regulatory/tax policy expertise; supports governance and oversight
Committee on Capital Markets RegulationCo-Chair2006–presentIndependent research leadership on market regulation; investments/risk perspective

External Roles

OrganizationRoleTenureNotes
BlackRock Fixed Income Funds (registered investment company complex)Director2019–presentFund complex of 67 registered investment companies; governance and investment oversight
TotalEnergies SE (non-U.S. listed)Director2021–presentGlobal energy firm board experience; regulated industry exposure
Automatic Data Processing, Inc.Director (prior)2004–2020Prior large-cap public company board service

Board Governance

  • Roles and Committees: Independent Chairman of the Board; member, Executive Committee (EC), Governance and Corporate Responsibility Committee (GC), and Investment Committee (IC) .
  • Independence: Board annually affirms independence; all Non-Management directors (including Hubbard) satisfy NYSE/SEC independence; principal standing committees are fully independent .
  • Leadership structure: Separate CEO and Chairman enhances independent oversight; Hubbard elected as independent Chair based on leadership and policy expertise .
  • Attendance and engagement: 2024 attendance at both regular Board and Committee meetings was 100% for applicable directors; each director exceeded 75% threshold; directors also attended the 2024 annual meeting . Executive sessions of Independent Directors held regularly; Chairman leads and facilitates board effectiveness and evaluations .
  • Evaluations: Annual board/committee evaluations; biennial individual self/peer evaluations led by the Chairman .

Fixed Compensation

ComponentAmount ($)Notes
Fees Earned or Paid in Cash (2024)275,000Includes Board retainer and Chairman of the Board retainer
All Other Compensation (2024)1,640Group life insurance ($1,584) and business travel accident insurance ($56)
Total Cash + Other (2024)276,640Sum of cash fees and other compensation

Director retainer schedule (approved in 2023; no meeting fees):

Retainer TypeAmount ($)
Board (cash)150,000
Board (fully vested shares value)175,000
Chairman of the Board (cash)125,000
Chairman of the Board (fully vested shares value)125,000
Committee Chair (cash) – Audit40,000
Committee Chair (cash) – Finance & Risk40,000
Committee Chair (cash) – Compensation30,000
Committee Chair (cash) – Governance & Corp. Responsibility25,000
Committee Chair (cash) – Investment25,000
  • Equity retainers are granted under director stock plans (2015 plan terminated effective 12/31/2024; 2025 plan effective 1/1/2025); grants vest immediately; no director stock options outstanding as of 12/31/2024 .

Performance Compensation

Grant Date (2024)Stock Awards Grant-Date Fair Value ($)Vesting Terms
January 2, 202475,028Fully vested shares at grant
April 1, 202475,016Fully vested shares at grant
June 18, 202475,030Fully vested shares at grant
October 1, 202475,074Fully vested shares at grant
Total (2024)300,148Sum of four annual equity installments
  • Director equity is service-based and immediately vested; no PSUs/RSUs with performance metrics for directors are disclosed; options awards are not outstanding for non-management directors .

Other Directorships & Interlocks

CompanyRoleStartPotential Interlock Considerations
BlackRock Fixed Income FundsDirector2019Registered investment company governance; MetLife is a large institutional investor and runs MIM, but no related-person transactions requiring disclosure since Jan 1, 2024; Board evaluates outside affiliations during independence review
TotalEnergies SEDirector2021Non-U.S. listed energy firm; regulated industry experience
ADP (prior)Director2004–2020Prior service; no current interlock
  • Related-Person Transactions: None requiring disclosure since January 1, 2024; governance policy requires Governance Committee review/approval for any potential related-person transactions .

Expertise & Qualifications

  • Regulated industry/government: Treasury, CEA, OECD roles provide deep policy/regulatory insight supporting oversight of risk, strategy, and compliance .
  • Investments and capital markets: Co-Chair of Committee on Capital Markets Regulation; BlackRock fund complex directorship .
  • Global literacy and sustainability: International policy leadership; sustainability highlighted among director competencies .

Equity Ownership

HolderCommon Stock (#)Exercisable Options (#)Deferred Shares (#)Total Beneficial Ownership (#)Percent of Class (%)Deferred Shares Not Beneficially Owned (#)
R. Glenn Hubbard7,904090,04597,949* (<1%) based on 674,385,252 shares1
  • Director ownership guidelines: Non-Management directors should hold at least 5x cash retainer; hedging and pledging of MetLife securities are prohibited for directors and employees . Individual compliance status versus guideline is not specifically disclosed; directors are expected to retain net shares from compensation distributions to meet guidelines .

Insider Trades (2025 filings)

Governance Assessment

  • Board effectiveness: Independent Chair structure, fully independent principal committees, rigorous annual and biennial evaluations, and regular executive sessions indicate strong oversight and accountability; 2024 attendance was exemplary (100%) enhancing investor confidence .
  • Compensation and alignment: Director pay balanced between cash and immediately vested equity; clear, market-based structure reviewed by independent consultant (Meridian), with no meeting fees and no director options; director equity aligns skin-in-the-game while prohibiting hedging/pledging to protect alignment .
  • Independence and conflicts: Annual independence review; limits on outside boards and audit committee service; no related-person transactions requiring disclosure in 2024; procedures in place for any future related-party review by Governance Committee—low conflict risk signal .
  • Shareholder signals: Strong say-on-pay support (95% in 2024) reflects broader governance credibility and investor alignment, though primarily tied to executive compensation program .

RED FLAGS

  • None disclosed regarding attendance shortfalls, related-party transactions, pledging/hedging, or pay anomalies for directors in 2024; governance policies explicitly prohibit hedging/pledging and mandate related-party reviews .